Skip to main content

and
  1. No Access

    Article

    Comparative Perioperative Outcomes by Esophagectomy Surgical Technique

    Surgical resection is vital in the curative management of patients with esophageal cancer. However, a myriad of surgical procedures exists based on surgeon preference and training. We report on the perioperati...

    Kenneth L. Meredith, Taylor Maramara, Paige Blinn in Journal of Gastrointestinal Surgery (2020)

  2. No Access

    Article

    Comparative long-term outcomes of upfront resected pancreatic cancer after preoperative biliary drainage

    We evaluated whether preoperative biliary drainage was predictive of recurrence and survival among patients with resectable pancreatic cancer.

    Tobin J. Strom, Jason B. Klapman, Gregory M. Springett in Surgical Endoscopy (2015)

  3. No Access

    Article

    Effect of Body Mass Index in Patients Undergoing Resection for Gastric Cancer: A Single Center US Experience

    With rising obesity in the USA, the impact of body mass index (BMI) on survival in gastric cancer remains unclear.

    Joyce Wong, Shams Rahman, Nadia Saeed, Hui-Yi Lin in Journal of Gastrointestinal Surgery (2014)

  4. No Access

    Article

    Prognostic Impact of Lymph Node Retrieval and Ratio in Gastric Cancer: a U.S. Single Center Experience

    Increased lymph node (LN) retrieval for gastric cancer has been associated with improved overall survival (OS). This study examines the impact of number of examined LN (eLN) and lymph node ratio.

    Joyce Wong, Shams Rahman, Nadia Saeed, Hui-Yi Lin in Journal of Gastrointestinal Surgery (2013)

  5. No Access

    Article

    Extent of Lymphadenectomy Does Not Predict Survival in Patients Treated with Primary Esophagectomy

    The number of lymph nodes resected and its impact on survival for patients with esophageal cancer remains undefined. Current guidelines recommend extended lymphadenectomy in patients not receiving neoadjuvant ...

    Joyce Wong, Jill Weber, Khaldoun Almhanna in Journal of Gastrointestinal Surgery (2013)

  6. No Access

    Article

    Initial experience from a large referral center with robotic-assisted Ivor Lewis esophagogastrectomy for oncologic purposes

    We report our initial experience of patients undergoing robotic-assisted Ivor Lewis esophagogastrectomy (RAIL) for oncologic purposes at a large-referral center.

    Sebastian G. de la Fuente, Jill Weber, Sarah E. Hoffe, Ravi Shridhar in Surgical Endoscopy (2013)

  7. Article

    Outcomes of definitive or preoperative IMRT chemoradiation for esophageal cancer

    Intensity-modulated radiation therapy (IMRT) is evolving for the treatment of gastrointestinal cancers. The purpose of this study is to analyze our outcomes utilizing IMRT chemoradiation for esophageal cancer.

    Ravi Shridhar, Michael D. Chuong, Jill Weber in Journal of Radiation Oncology (2012)

  8. No Access

    Article

    Body Mass Index and Survival in Esophageal Adenocarcinoma Treated with Chemoradiotherapy Followed by Esophagectomy

    Body mass index (BMI) has been linked with inferior outcomes in gastrointestinal malignancies. The purpose of this study is to evaluate the effect of BMI on survival in patients with esophageal adenocarcinoma.

    Ravi Shridhar, Thomas Hayman, Sarah E. Hoffe in Journal of Gastrointestinal Surgery (2012)

  9. Article

    Outcomes of anal cancer treated with definitive IMRT-based chemoradiation

    Despite excellent long-term outcomes, definitive chemoradiation (CRT) for squamous cell carcinoma (SqCC) of the anal canal with traditional radiotherapy techniques results in significant morbidity. Accruing da...

    Michael D. Chuong, Sarah E. Hoffe, Jill Weber in Journal of Radiation Oncology (2012)

  10. No Access

    Article

    Pathologic Response after Neoadjuvant Therapy is the Major Determinant of Survival in Patients with Esophageal Cancer

    Esophageal cancer remains a malignancy with high morbidity and mortality despite improvements to diagnosis, staging, chemotherapy, radiation, and surgery. Neoadjuvant therapy (NT) may improve oncologic outcome...

    Kenneth L. Meredith, Jill M. Weber, Kiran K. Turaga in Annals of Surgical Oncology (2010)